Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.00005 GBP per share
-
Shares outstanding
-
25,770,441,176
-
Total 13F shares
-
21,314
-
Share change
-
+14,072
-
Total reported value
-
$28,132
-
Price per share
-
$1.32
-
Number of holders
-
6
-
Value change
-
+$18,574
-
Number of buys
-
4
Institutional Holders of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) as of Q1 2025
As of 31 Mar 2025 Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) had 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,314 shares of stock of the company.
Largest 6 holders included UBS Group AG, GAMMA Investing LLC, MORGAN STANLEY, RHUMBLINE ADVISERS, CONTRAVISORY INVESTMENT MANAGEMENT, INC., and SBI Securities Co., Ltd..
This table shows 6 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.